Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biophys Chem ; 278: 106660, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34482215

RESUMEN

Schistosomiasis is one of the neglected diseases causing considerable morbidity and mortality throughout the world. Microtubules with its main component, tubulin play a vital role in helminthes including schistosomes. Benzimidazoles represent potential drug candidates by binding ß-tubulin. The study aimed to generate a homology model for the ß-tubulin of S. mansoni using the crystal structure of O visaries (Sheep) ß-tubulin (PDB ID: 3N2G D) as a template, then different ß-tubulin models were generated and two previously reported benzimidazole derivatives (NBTP-F and NBTP-OH) were docked to the generated models, the binding results indicated that both S. mansoni, S. haematobium were susceptible to the two NBTP derivatives. Additionally, three mutated versions of S. mansoni ß-tubulin wild-type were generated and the mutation (F185Y) seems to slightly enhance the ligand binding. Dynamics simulation experiments showed S. haematobium ß-tubulin is highly susceptible to the tested compounds; similar to S. mansoni, moreover, mutated models of S. mansoni ß-tubulin altered its NBTPs susceptibility. Moreover, additional seven new benzimidazole derivatives were synthesized and tested by molecular docking on the generated model binding site of S. mansoni ß-tubulin and were found to have good interaction inside the pocket.


Asunto(s)
Schistosoma mansoni , Tubulina (Proteína) , Animales , Sitios de Unión , Simulación del Acoplamiento Molecular , Simulación de Dinámica Molecular , Schistosoma mansoni/metabolismo , Ovinos , Tubulina (Proteína)/química , Tubulina (Proteína)/metabolismo
2.
Parasitol Res ; 112(12): 4221-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24096606

RESUMEN

Currently, praziquantel is the only drug of choice for treatment of schistosomiasis. Reports of praziquantel resistance raise concerns about future control of the disease. Therefore, the search for new schistosomicidal drugs is eminent. In this study, the effect of a novel benzimidazole-derived compound (compound BTP-Iso) was assessed in mice harboring adult Schistosoma mansoni (Egyptian strain). Mice were treated 42 days p.i. with compound BTP-Iso using two treatment regimens (200 or 300 mg/kg). In both regimens, there were significant reductions in the number of recovered S. mansoni worms especially females and in immature ova, in addition to a significant reduction in the number and size of hepatic granulomata. A dose of 300 mg/kg resulted in a significant decrease in intestinal and hepatic tissue egg loads. Effect on schistosomes was confirmed by scanning electron microscopy, where adult worms recovered from mice treated with 200 mg/kg of compound BTP-Iso revealed tegumental alternations, characterised by swelling of tegumental ridges, bleb formation, and mild erosion in male worms; however in females, there were extensive erosion and destruction of the tegumental surface. These promising results may encourage future use of compound BTP-Iso in the treatment of schistosomiasis. However, more research is needed to detect the effect of compound BTP-Iso on early developmental stages of S. mansoni and on other species of human schistosomes.


Asunto(s)
Bencimidazoles/farmacología , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomicidas/farmacología , Animales , Femenino , Intestinos/parasitología , Hígado/parasitología , Hígado/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica de Rastreo , Estructura Molecular , Carga de Parásitos , Schistosoma mansoni/ultraestructura , Esquistosomicidas/uso terapéutico
3.
Arch Pharm (Weinheim) ; 344(12): 821-9, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21932255

RESUMEN

In research for promising antibacterial and antifungal compounds, a series of 2-aryl 3-[1,2,4]triazol-5-yl 4-thiazolidinones 1 were synthesized by a domino reaction of 5-amino-1H-[1,2,4]triazoles 3, aromatic aldehydes, and α-mercaptoacids in boiling toluene in the presence of molecular sieves 4 Å. Of the twenty novel 3-[1,2,4]triazol-5-yl 4-thiazolidinone derivatives, four compounds 2-benzo[d][1,3]dioxol-6-yl-3-[(3-morpholin-4-yl)-1H-1,2,4-triazol-5-yl)]-1,3-thiazolidin-4-one (1i), 2-(4-chlorophenyl)-5-methyl-3-[3-(4-methylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-1,3-thiazolidin-4-one (1p), 2-benzo[d][1,3]dioxol-6-yl-3-[3-(4-methylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-1,3-thiazolidin-4-one (1s), 2-benzo[d][1,3]dioxol-6-yl-5-methyl-3-[3-(4-methylpiperazin-1-yl)-1H-1,2,4-triazol-5-yl]-1,3-thiazolidin-4-one (1t) exhibited MICs of 4 µg/mL or less versus Mycobacterium tuberculosis. Moreover, these compounds were screened against Candida albicans. Compounds 1p, 1s gave MICs of 1 µg/mL or less, and were fungicidal. Finally, compound 1s was evaluated against an expanded fungal panel and showed good activity against Cryptococcus neoformans. In addition, compound 1s also appeared to be fungicidal against Aspergillus arrhizus, with MIC <1 µg/mL.


Asunto(s)
Antifúngicos/síntesis química , Antituberculosos/síntesis química , Triazoles/síntesis química , Antifúngicos/farmacología , Antituberculosos/farmacología , Pruebas de Sensibilidad Microbiana , Relación Estructura-Actividad , Triazoles/farmacología
4.
Nat Prod Res ; 22(13): 1176-88, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18855219

RESUMEN

An asymmetric induction using (S)-1-arylethylamine-based chiral auxiliary and two Bu(3)SnH-mediated radical cyclisations have been developed for a total synthesis of (-)-gamma-lycorane (1). The first cyclisation proceeded in 5-endo-trig manner with moderate diastereoselectivtiy to give (3aR,7aR)-octahydroindol-2-one 6b as the major product using alpha-iodo-N-(6-oxocyclohexen-1-yl)-N-[(S)-1-phenylethyl] acetamide (5b). In the second cyclisation, the radical precursor 8 was used as substrate to construct the optically active lycorane skeleton 15 which was reduced using LiAlH4 into (-)-gamma-lycorane (1).


Asunto(s)
Alcaloides/química , Alcaloides/síntesis química , Alcaloides de Amaryllidaceae/química , Ciclización , Espectroscopía de Resonancia Magnética , Estructura Molecular
5.
Spectrochim Acta A Mol Biomol Spectrosc ; 68(5): 1278-86, 2007 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-17398144

RESUMEN

The present work carried out a study on perchlorate mixed-ligand copper(II) complexes which have been synthesized from ethylenediamine derivatives (3a-c) and beta-diketones. These complexes, namely [Cu(DA-Cl)(acac)H(2)O]ClO(4)4, [Cu(DA-Cl)(bzac)H(2)O]H(2)O.ClO(4)5, [Cu(DA-OMe)(acac)H(2)O]ClO(4)6, [Cu(DA-OMe)(bzac)H(2)O]ClO(4)7, [Cu(DA-H)(acac)H(2)O]2H(2)O.ClO(4)8 and [Cu(DA-H)(bzac)H(2)O]ClO(4)9 (where acac, acetylacetonate and bzac, benzoylacetonate) were characterized by elemental analysis, spectral (IR and UV-vis) and magnetic moment measurements. Thermal properties and decomposition kinetics of all complexes are investigated. The interpretation, mathematical analysis and evaluation of kinetic parameters (E, A, DeltaH, DeltaS and DeltaG) of all thermal decomposition stages have been evaluated using Coats-Redfern equation. The biochemical studies showed that, the diamines 3a-c have powerful effects on degradation of DNA and protein. The antibacterial screening demonstrated that, the diamine (DA-Cl), 3b has the maximum and broad activities against Gram +ve and Gram -ve bacterial strains.


Asunto(s)
Cobre/química , Etilenodiaminas/química , Cetonas/química , Percloratos/química , Temperatura , Animales , Antibacterianos/química , Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Bovinos , Cobre/farmacología , ADN Bacteriano/metabolismo , Análisis Diferencial Térmico , Electrones , Etilenodiaminas/farmacología , Cetonas/farmacología , Cinética , Ligandos , Magnetismo , Pruebas de Sensibilidad Microbiana , Percloratos/farmacología , Albúmina Sérica Bovina/metabolismo , Espectrofotometría Infrarroja , Superóxidos/metabolismo , Termogravimetría
6.
Arch Pharm (Weinheim) ; 338(1): 38-43, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15674803

RESUMEN

In a search for promising antibacterial and antifungal compounds, two new series of 2, 3-bis(5-alkyl-2-thiono-1, 3, 5-thiadiazin-3-yl)propionic acid 1 and their corresponding N, N-dimethylpropionamide 6 have been synthesized. The reaction of 2, 3-diaminopropionate 3, carbon disulfide, formaldehyde, and the appropriate alkyl amines furnished the title compound 1. N, N-dimethylpropionamides 6 were obtained by the reaction of 1 with dimethyl amine in the presence of POCl(3). The newly prepared compounds were screened in vitro against certain strains of Gram-positive and Gram-negative bacteria and compared with nalidixic acid and ciprofloxacin. Moreover, the title compounds were tested for their antifungal activity in vitro against Candida albicans, phytopathogenic, Penicillum expansum and Trichoderma hazianum, and aflatoxin-producing Aspergillus flavus. These compounds exhibit varied activity against the tested pathogenic bacteria and remarkable inhibitory effects on growth or sporulation of some of the tested fungal species.


Asunto(s)
Antibacterianos/síntesis química , Antifúngicos/síntesis química , Propionatos/síntesis química , Tiadiazinas/síntesis química , Tionas/síntesis química , Antibacterianos/farmacología , Antifúngicos/farmacología , Aspergillus flavus/efectos de los fármacos , Candida albicans/efectos de los fármacos , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Propionatos/farmacología , Relación Estructura-Actividad , Tiadiazinas/farmacología , Tionas/farmacología , Trichoderma/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...